PMID: 6985948Feb 1, 1980Paper

Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties

The Journal of Investigative Dermatology
P R BergstresserJ W Streilein

Abstract

Epidermal Langerhans cells bear surface receptors which implicate them as immunocompetent cells and they are now felt to play an important role both in delayed hypersensitivity and in skin allograft reactions. To determine the relationship between Langerhans cell availability and certain immunologic phenomena, surface densities were determined by ATP-ase and gold uptake in 3 rodent species: guinea pig, hamster, and mouse. Surface densities in epidermal specimens from the ear, back, foot pad, and buccal mucosa varied between 600 and 1500 cells/mm2. Significantly fewer cells were found in the hamster cheek pouch (130 cells/mm2) and in the mouse tail (110 cells/mm2 for C57BL/6J; 260 cells/mm2 for BALB/c nu/nu). Langerhans cells were absent from the central port;on of the cornea in all 3 species. Decreased Langerhans cell surface density may contribute to immunologic privilege as has been observed for the cornea and hamster cheek pouch and to the unusual allograft characteristics of mouse tail skin.

Citations

Dec 1, 1987·European Journal of Immunology·H J SchildV Schirrmacher
Jul 1, 1995·Revista Do Instituto De Medicina Tropical De São Paulo·M S de Arruda, M R Montenegro
May 19, 2000·Annals of the New York Academy of Sciences·J W StreileinH Niizeki
Mar 13, 2003·Immunology and Cell Biology·Michael A ThielKeryn A Williams
Sep 10, 2010·Current Opinion in Allergy and Clinical Immunology·Gabriela SentiThomas M Kundig
Jan 1, 1988·Archives of Virology·E Sprecher, Y Becker
Dec 1, 1985·The British Journal of Dermatology·H ChenW K Silvers
Jan 1, 1989·Toxicology and Industrial Health·M L SternA E Munson
Sep 1, 1987·The Journal of Dermatologic Surgery and Oncology·A M ShaiebP Krumpe
Nov 1, 1983·The British Journal of Dermatology·B BermanG Petroni
Jan 1, 1983·Archives of Dermatological Research·H Mittag, G Klingmüller
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·L TimaresS A Johnston
Oct 2, 2007·Transplant International : Official Journal of the European Society for Organ Transplantation·Benjamin M HornerPeter E M Butler
Jul 10, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Angelika StoecklingerPeter Hammerl
Apr 28, 2009·Expert Opinion on Biological Therapy·Wellington PhamJohn C Gore
Aug 26, 2015·Parasitology·Karlien BarnardSonja Matthee
Jan 1, 1989·Allergy·L P RucoC D Baroni
Nov 1, 1986·Immunological Investigations·C A PicutR M Lewis
May 1, 1985·Journal of Oral Pathology·E E AhlforsP R Bergstresser
Jan 1, 1982·Annals of the New York Academy of Sciences·J W StreileinP Strome
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laura TimaresStephen Albert Johnston
Feb 25, 2009·Current Protocols in Immunology·Hugh I McFarland, Amy S Rosenberg
Jan 11, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·T J BorgesL V Riella
Dec 1, 1981·The Journal of Dermatologic Surgery and Oncology·J SchwartzR Weichselbaum
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sanjay PradhanLaura Timares
Apr 25, 2008·Current Protocols in Immunology·A S Rosenberg
Jul 1, 1981·The British Journal of Dermatology·K M HalprinJ R Taylor
Apr 2, 2004·The Journal of Clinical Investigation·Igor M BelyakovJay A Berzofsky
Oct 20, 2010·Xenotransplantation·Hidetaka Hara, David K C Cooper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.